Wang Yanfang, Nie Fang, Wang Guojuan, Liu Ting, Dong Tiantian, Sun Yamin
Medical Center of Ultrasound, Lanzhou University Second Hospital, Lanzhou, Gansu, People's Republic of China.
Department of Pathology, Lanzhou University Second Hospital, Lanzhou, Gansu, People's Republic of China.
Cancer Manag Res. 2021 Apr 19;13:3403-3415. doi: 10.2147/CMAR.S299157. eCollection 2021.
Early and accurate preoperative diagnosis of central lymph node metastasis (CLNM) is crucial to improve surgical management of patients with clinical lymph node-negative papillary thyroid carcinoma (PTC). Towards improving diagnosis of CLNM, we assessed the value of combining preoperative clinical characteristics, conventional ultrasound, and contrast-enhanced ultrasound (CEUS) in preoperative prediction of CLNM of different sized PTCs.
Patients were divided according to tumor size: a PTC group (>10 mm) and a papillary thyroid microcarcinoma (PTMC) group (≤10 mm). We retrospectively analyzed the clinical and ultrasonographic features of 120 PTC patients and 165 PTMC patients. Multivariate logistic regression analysis was used to screen independent risk factors and establish prediction models. Receiver operating characteristic curves were used to determine the best cut-off values for continuous variables and assess the performance of prediction models.
Independent risk predictors of CLNM for the PTC group were extrathyroidal extension in CEUS (OR=7.923), tumor size >14 mm (OR=5.491), and multifocality (OR=3.235). For the PTMC group, the independent risk factors were the distance from the thyroid capsule =0 mm (OR=4.629), male (OR=3.315), tumor size >5 mm (OR=3.304), and microcalcification (OR=2.560). The predictive model of combined method had better performance in predicting CLNM of PTC compared with models based on CEUS and conventional ultrasound alone (area under the curve: 0.832 vs 0.739, =0.0011; 0.832 vs 0.678, =0.0012). For PTMC, comparing with CEUS, the combined method and conventional ultrasound performed better than CEUS alone in predicting CLNM (area under the curve: 0.783 vs 0.636, =0.0016; 0.738 vs 0.636, =0.0196).
The predictive models of combined method obtained from significant preoperative clinical and ultrasonographic features can potentially improve the preoperative diagnosis and individual treatment of CLNM in patients with PTC and PTMC. CEUS may be helpful in predicting CLNM of PTC, but CEUS would be ineffective in predicting CLNM of PTMC.
早期准确的术前中央淋巴结转移(CLNM)诊断对于改善临床淋巴结阴性的乳头状甲状腺癌(PTC)患者的手术管理至关重要。为了提高CLNM的诊断水平,我们评估了术前临床特征、传统超声和超声造影(CEUS)相结合在不同大小PTC患者CLNM术前预测中的价值。
根据肿瘤大小将患者分组:PTC组(>10mm)和甲状腺微小乳头状癌(PTMC)组(≤10mm)。我们回顾性分析了120例PTC患者和165例PTMC患者的临床及超声特征。采用多因素logistic回归分析筛选独立危险因素并建立预测模型。采用受试者操作特征曲线确定连续变量的最佳截断值并评估预测模型的性能。
PTC组CLNM的独立风险预测因素为CEUS中的甲状腺外侵犯(OR=7.923)、肿瘤大小>14mm(OR=5.491)和多灶性(OR=3.235)。对于PTMC组,独立危险因素为距甲状腺被膜距离=0mm(OR=4.629)、男性(OR=3.315)、肿瘤大小>5mm(OR=3.304)和微钙化(OR=2.560)。与单独基于CEUS和传统超声的模型相比,联合方法的预测模型在预测PTC的CLNM方面具有更好的性能(曲线下面积:0.832对0.739,P=0.0011;0.832对0.678,P=0.0012)。对于PTMC,与CEUS相比,联合方法和传统超声在预测CLNM方面比单独的CEUS表现更好(曲线下面积:0.783对0.636,P=0.0016;0.738对0.636,P=0.0196)。
从术前重要临床和超声特征获得的联合方法预测模型可能会改善PTC和PTMC患者CLNM的术前诊断和个体化治疗。CEUS可能有助于预测PTC的CLNM,但CEUS在预测PTMC的CLNM方面无效。